AI assistant
REGENXBIO Inc. — Director's Dealing 2018
Nov 5, 2018
32827_dirs_2018-11-05_d71b1bff-a2ab-4404-b3b9-415185f3ffa2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENXBIO Inc. (RGNX)
CIK: 0001590877
Period of Report: 2018-11-01
Reporting Person: Vasista Vittal (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-01 | Common Stock | M | 9959.00 | $3.76 | Acquired | 147242.00 | Direct |
| 2018-11-01 | Common Stock | M | 9718.00 | $13.09 | Acquired | 156960.00 | Direct |
| 2018-11-01 | Common Stock | S | 19677.00 | $70.04 | Disposed | 137283.00 | Direct |
| 2018-11-02 | Common Stock | M | 32908.00 | $13.09 | Acquired | 170191.00 | Direct |
| 2018-11-02 | Common Stock | M | 20833.00 | $19.50 | Acquired | 191024.00 | Direct |
| 2018-11-02 | Common Stock | S | 53741.00 | $70.26 | Disposed | 137283.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-11-01 | Employee Stock Option (Right to Buy) | $3.76 | M | 9959.00 | Disposed | 2025-05-18 | Common Stock (9959.00) | Direct |
| 2018-11-01 | Employee Stock Option (Right to Buy) | $13.09 | M | 9718.00 | Disposed | 2026-01-27 | Common Stock (9718.00) | Direct |
| 2018-11-02 | Employee Stock Option (Right to Buy) | $13.09 | M | 32908.00 | Disposed | 2026-01-27 | Common Stock (32908.00) | Direct |
| 2018-11-02 | Employee Stock Option (Right to Buy) | $19.50 | M | 20833.00 | Disposed | 2027-01-03 | Common Stock (20833.00) | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F2: This transaction was executed in multiple trades at prices ranging from $70.00 to $70.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $70.00 to $70.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer.
F5: The previously granted option, representing a right to purchase a total of 75,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 28, 2017, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer.
F6: The previously granted option, representing a right to purchase a total of 50,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer.